Clinical Division Faculty

My
primary research focus is in the area of epidemiology, prediction and
prevention of type 1 diabetes. I have a background in pediatric endocrinology,
with specific training and expertise in pediatric diabetes. My research
experience includes work with epidemiological studies such as DAISY (Diabetes
Autoimmunity Study in the Young) and TEDDY (The Environmental Determinants of
Diabetes in the Young). Currently, I am the PI for an ADA Career Development
Award on Determinants of rate of progression to type 1 diabetes in TrialNet
subjects at high risk of developing type 1 diabetes, as well as the PI of the
Twin Family Study and the Monogenic Diabetes Study at the Barbara Davis Center,
investigating monogenic forms of diabetes. I am also the Colorado PI for
several multisite research studies, including the TrialNet Pathway to
Prevention Study, the TrialNet Oral Insulin Trial, the LIFT (Long-Term
Investigative Follow-Up in TrialNet) Study, and the JDRF Follow-up of Children
Diagnosed with Diabetes Study, looking at preservation of C-peptide over time
in children diagnosed with type 1 diabetes through prospective studies such as
TEDDY compared to type 1 diabetes controls from the community. My goal is to
further characterize staging of risk for type 1 diabetes, pathophysiology and
preservation of endogenous insulin secretion in collaboration with local and
national colleagues.